로딩 중…
지수 로딩 중…
Ray Co., Ltd.
228670· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,670-9.28%
2026-08-04
Financials
Valuation Metrics
Ray Co., Ltd.'s Market Cap is ₩887B. At end of 2025 it was ₩1059B. Ranked #1239 of 2,436 in KR market (top 51%), #663 of 1,649 on KOSDAQ (top 40%), #47 of 96 in Health Care Equipment & Services (top 49%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 88.68B KRW | KR#1,239/2,436 Sec#47/96 |
| Revenue | 112.53B KRW | KR#1,334/2,436 Sec#28/96 |
| Net Income | 993.4M KRW | KR#1,426/2,436 Sec#46/96 |
| Total Assets | 176.31B KRW | KR#1,362/2,436 Sec#40/96 |
| Net Assets | 78.47B KRW | KR#1,573/2,436 Sec#46/96 |
| Employees | 183 | KR#1,152/2,436 Sec#34/96 |
| Value | ||
| P/E | 89.27x | KR#1,439/2,436 Sec#46/96 |
| P/B | 1.13x | KR#1,695/2,436 Sec#52/96 |
| PEG | 4.16x | KR#830/2,436 Sec#34/96 |
| P/S | 0.79x | KR#1,320/2,436 Sec#22/96 |
| FCF Yield | 12.66% | KR#581/2,436 Sec#11/96 |
| Profitability | ||
| ROE | 1.27% | KR#1,399/2,436 Sec#47/96 |
| ROA | 0.56% | KR#1,401/2,436 Sec#46/96 |
| Op. Margin | -11.93% | KR#2,021/2,436 Sec#67/96 |
| Revenue Growth | 4.94% | KR#1,166/2,436 Sec#58/96 |
| Earnings Growth | 21.48% | KR#740/2,436 Sec#31/96 |
| Financial Health | ||
| Debt Ratio | 224.68% | KR#1,870/2,436 Sec#83/96 |
| Total Debt | 62.28B KRW | KR#893/2,436 Sec#20/96 |
| FCF | 11.22B KRW | KR#683/2,436 Sec#15/96 |
| Cash | 23.16B KRW | KR#1,152/2,436 Sec#28/96 |
| Current Ratio | 1.32x | KR#1,446/2,436 Sec#72/96 |
| Performance | ||
| 1Y Return | -21.36% | KR#981/2,436 Sec#23/96 |
| 1M Return | 22.20% | KR#38/2,436 Sec#1/96 |
| From 52W High | -51.50% | KR#957/2,436 Sec#38/96 |
| 1Y MDD | -63.82% | KR#1,630/2,436 Sec#55/96 |
| Trading | ||
| Volume | 294,072 shares | KR#146/2,436 Sec#7/96 |
| Foreign Own. | 4.65% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 230 KRW | KR#1,168/2,436 Sec#37/96 |
| BPS | 5,137 KRW | KR#1,415/2,436 Sec#36/96 |
Company Info
Ray, established in 2004, aims to manufacture dental medical device equipment and develop software, and was listed on KOSDAQ in 2019. The company has expanded globally, establishing legal entities in France (2021), China (2022), and India (2023), now operating sales bases in 13 countries. Ray is the only domestic company with a full line-up of dental digital imaging systems, providing digital diagnostic systems and treatment solutions. It is headquartered in Seongnam-si, Gyeonggi-do.